deltatrials
Completed PHASE1/PHASE2 INTERVENTIONAL 4-arm NCT00604890

Dose-Ranging Clinical Trial of Topical Creams Containing API 31510 for the Treatment of Superficial Basal Cell Carcinoma

Sponsor: BPGbio

Updated 10 times since 2017 Last updated: Feb 14, 2025 Started: Mar 31, 2008 Primary completion: Jan 31, 2010 Completion: Jan 31, 2010
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE1/PHASE2 trial investigates Superficial Basal Cell Carcinoma and is currently completed. BPGbio leads this study, which shows 10 recorded versions since 2008 — indicating substantial longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.

Status Flow

~Jan 2017 – ~Feb 2017 · 31 days · monthly snapshotCompleted~Feb 2017 – ~Jun 2018 · 16 months · monthly snapshotCompleted~Jun 2018 – ~Apr 2019 · 10 months · monthly snapshotCompleted~Apr 2019 – ~Jan 2021 · 21 months · monthly snapshotCompleted~Jan 2021 – ~Dec 2022 · 23 months · monthly snapshotCompleted~Dec 2022 – ~Jan 2023 · 31 days · monthly snapshotCompleted~Jan 2023 – ~Jul 2024 · 18 months · monthly snapshotCompleted~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotCompleted~Sep 2024 – ~Mar 2025 · 6 months · monthly snapshotCompleted~Mar 2025 – present · 17 months · monthly snapshotCompleted

Change History

10 versions recorded
  1. Mar 2025 — Present [monthly]

    Completed PHASE1/PHASE2

  2. Sep 2024 — Mar 2025 [monthly]

    Completed PHASE1/PHASE2

  3. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE1/PHASE2

    Phase: PHASE1_PHASE2PHASE1/PHASE2

  4. Jan 2023 — Jul 2024 [monthly]

    Completed PHASE1_PHASE2

  5. Dec 2022 — Jan 2023 [monthly]

    Completed PHASE1_PHASE2

Show 5 earlier versions
  1. Jan 2021 — Dec 2022 [monthly]

    Completed PHASE1_PHASE2

  2. Apr 2019 — Jan 2021 [monthly]

    Completed PHASE1_PHASE2

    Phase: PHASE2PHASE1_PHASE2

  3. Jun 2018 — Apr 2019 [monthly]

    Completed PHASE2

  4. Feb 2017 — Jun 2018 [monthly]

    Completed PHASE2

  5. Jan 2017 — Feb 2017 [monthly]

    Completed PHASE2

    First recorded

Mar 2008

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • BPGbio
Data source: BPGbio

For direct contact, visit the study record on ClinicalTrials.gov .